• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Micel Corporation

Micel Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Alnylam Files Clinical Trial Application (CTA) for ALN-AAT, an Investigational RNAi Therapeutic for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease (Alpha-1 Liver Disease)

    Alnylam Files Clinical Trial Application (CTA) for ALN-AAT, an Investigational RNAi Therapeutic for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease (Alpha-1 Liver Disease)

  2. NuSirt Biopharma to Present at American Diabetes Association's 75th Scientific Sessions

    NuSirt Biopharma to Present at American Diabetes Association's 75th Scientific Sessions

  3. Cortendo AB: Cortendo and Antisense Therapeutics Announce Licensing Agreement for ATL1103 for Acromegaly

    Cortendo AB: Cortendo and Antisense Therapeutics Announce Licensing Agreement for ATL1103 for Acromegaly

  4. FibroGen Announces Receipt of Milestone Payment from AstraZeneca for Successful Completion of Long-Term Pre-Clinical Safety Studies of Roxadustat

    FibroGen Announces Receipt of Milestone Payment from AstraZeneca for Successful Completion of Long-Term Pre-Clinical Safety Studies of Roxadustat

  5. Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates

    Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates

  6. A Dynamic Productivity Duo

    Advisors spend a lot on their machines, but they sometimes ignore productivity-boosting peripherals.

  7. Mouse/Presenter Combo Simplifies Your Travel Gear

    Despite terrible documentation, this solution is a winner.

  8. A Mouse and Keyboard for Discriminating Advisors

    Taking a test drive of the Logitech Cordless Desktop MX 5500 Revolution.

  9. PayPal Co-Founder Peter Thiel is Betting Against Recovery

    Peter Thiel is best known as the guy who cofounded and ran PayPal before selling it to eBay for $1.5 billion in 2002. Since then, he's founded a $2 billion hedge fund, Clarium Capital, and the Founders Fund, a venture fund. Peter is also one of Facebook's earliest investors and now sits on the ...

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.